LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Synonym joins EuropaBio: Together for Advancing the Global Bioeconomy

18/02/2025

PRESS RELEASE

Brussels, 18 February 2025 - EuropaBio is pleased to announce that Synonym has joined the association.

Based in New York City, Synonym commercializes bioproducts, offering a suite of software and technology to accelerate bioproducts to market. Scaler provides techno-economic analysis and planning tools for companies bringing bioproducts to market. Match powered by Capacitor, is a production management solution leveraging the largest global network of biomanufacturing infrastructure. iProof is a state-of-the-art milestone-scale facility in development in partnership with Primient located in Decatur, Illinois. Leveraging its unique data, design, and development capabilities, Synonym identifies and scales the most promising bioproducts to deliver a future powered by biology.

In joining EuropaBio, Synonym brings its unique data and knowledge that helps to unlock production at an industrial scale expertise, while being an ecosystem player connecting biotechnology producers, manufacturers, and buyers. Their goal is to contribute to the success of the bioeconomy in the EU. By partnering with EuropaBio members to evaluate ways to scale up production and deliver biomanufacturing infrastructure projects in Europe.

Dr. Claire Skentelbery, Director General of EuropaBio said ‘’Synonym is an example of how innovation for all aspects of biomanufacturing is essential to success. Enabling biomanufacturing is not just about having capacity, it’s also about being able to use that capacity. They will be essential to EU strategy for delivering economic growth through biotech.’’

Edward Shenderovich, Co-founder and CEO of Synonym added ‘’We’re thrilled to join EuropaBio. Advancing the bioeconomy requires deep industry collaboration and we are happy to join a consortium focused on incubating just that ecosystem. We believe Synonym’s tool can greatly benefit all consortium members.”

For more information on Synonym, please visit synonym.bio.

Synonym joins EuropaBio: Together for Advancing the Global Bioeconomy


Download
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.